Investor Alert

Regeneron Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

May 26, 2023, 6:21 p.m.





-0.10 -0.01%


Volume 44,576

Quotes are delayed by 20 min


Previous close

$ 725.00

$ 725.05


+0.05 +0.0069%

Day low

Day high




52 week low

52 week high




Annual Financials for Regeneron Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Sales/Revenue 6.71B6.56B8.5B16.07B12.17B
Cost of Goods Sold (COGS) incl. D&A 582.3M975.4M1.36B2.72B1.9B
COGS excluding D&A 434.1M765.1M1.12B2.44B1.56B
Depreciation & Amortization Expense 148.2M210.3M235.9M286.2M341.4M
Depreciation 148.2M210.3M235.9M286.2M303.8M
Amortization of Intangibles ----37.6M
Gross Income 6.13B5.58B7.14B13.35B10.27B
20182019202020212022 5-year trend
SG&A Expense 3.59B3.58B3.85B4.45B5.17B
Research & Development 2.04B2.24B2.5B2.62B3.06B
Other SG&A 1.56B1.34B1.35B1.82B2.12B
Other Operating Expense -(209.2M)(280.4M)(45.6M)(89.9M)
Unusual Expense 41.9M(118.3M)(196M)(386.1M)489.9M
EBIT after Unusual Expense 2.49B118.3M3.77B9.33B4.7B
Non Operating Income/Expense 89.2M131.2M94.7M50.2M59M
Non-Operating Interest Income ----160.1M
Equity in Affiliates (Pretax) -----
Interest Expense 28.2M30.2M56.9M57.3M59.4M
Gross Interest Expense 28.2M30.2M56.9M57.3M59.4M
Interest Capitalized -----
Pretax Income 2.55B2.43B3.81B9.33B4.86B
Income Tax 109.1M313.3M297.2M1.25B520.4M
Income Tax - Current Domestic 228.5M446.5M200.2M1.44B975.9M
Income Tax - Current Foreign 20.6M(2.6M)21.4M(38.4M)290.9M
Income Tax - Deferred Domestic 685.7M(133.7M)107M(423.8M)(800.4M)
Income Tax - Deferred Foreign (825.7M)3.1M(31.4M)276.7M54M
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 2.44B2.12B3.51B8.08B4.34B
Minority Interest Expense -----
Net Income 2.44B2.12B3.51B8.08B4.34B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 2.44B2.12B3.51B8.08B4.34B
Preferred Dividends -----
Net Income Available to Common 2.44B2.12B3.51B8.08B4.34B
EPS (Basic) 22.6519.3832.6576.4040.51
Basic Shares Outstanding 107.9M109.2M107.6M105.7M107.1M
EPS (Diluted) 21.2918.4630.5271.9738.22
Diluted Shares Outstanding 114.8M114.6M115.1M112.2M113.5M
EBITDA 2.68B2.42B3.81B9.23B5.53B
Link to MarketWatch's Slice.